Showing results (1771-1780 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|January 27, 2019
Hybrid Capture-Based Genomic Profiling Identifies BRAF V600 and Non-V600 Alterations in Melanoma Samples Negative by Prior TestingLise Boussemart, Annie Nelson, Michael Wong, et al.
The Oncologist|January 18, 2019
Long-Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid SyndromeLowell B Anthony, Matthew H Kulke, Martyn E Caplin, et al.
The Oncologist|February 8, 2019
Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder CancerChelsea K Osterman, Dilip S Babu, Daniel M Geynisman, et al.
The Oncologist|February 8, 2019
Feasibility Assessment of Using the Complete Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) Item LibraryDaniel Shepshelovich, Kate McDonald, Anna Spreafico, et al.
The Oncologist|December 19, 2019
Exceptional Response of Cryoablation Followed by Pembrolizumab in a Patient with Metastatic Cervical Carcinosarcoma with High Tumor Mutational Burden: A Case ReportBaorang Zhu, Ying Liu, Jing Li, et al.
The Oncologist|December 21, 2019
A Pilot Feasibility Study of Yttrium-90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver MetastasesChongkai Wang, John Park, Ching Ouyang, et al.
The Oncologist|December 22, 2019
Breakthrough Cancer Pain in Patients Receiving Low Doses of Opioids for Background PainSebastiano Mercadante, Augusto Caraceni, Francesco Masedu, et al.
The Oncologist|December 25, 2019
Best Practices in the Management of Nonmedical Opioid Use in Patients with Cancer-Related PainEsad Ulker, Egidio Del Fabbro
The Oncologist|December 25, 2019
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance)Kaushal Parikh, Sumithra J Mandrekar, Katie Allen-Ziegler, et al.
The Oncologist|December 27, 2019
Phase I Trial of a Modified Vaccinia Ankara Priming Vaccine Followed by a Fowlpox Virus Boosting Vaccine Modified to Express Brachyury and Costimulatory Molecules in Advanced Solid TumorsJulie M Collins, Renee N Donahue, Yo-Ting Tsai, et al.
Pageof 571